NSE · ORCHPHARMA
Orchid Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#754
of 5,072 stocks
▲ 171W
Peak #754 · 27 Sep 2026
Orchid Pharma Limited is a midcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 70%.
Market Cap
6,377.17 Cr
P/E Ratio
262.94
P/B Ratio
4.19
ROE
1.60%
ROCE
2.50%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 304.17 Cr | 237.61 Cr | 207.27 Cr | 193.52 Cr |
| Net Profit | 3.22 Cr | 23.78 Cr | -12.61 Cr | -5.72 Cr |
| EPS | 0.54 | 4.69 | -2.49 | -1.13 |
| Operating Profit | 4.88 Cr | 25.34 Cr | -1.86 Cr | 39.74 L |
Shareholding pattern
Promoter
69.84%
Public
30.16%
Mutual fund holdings
₹921.71
Cr total
20
Schemes
8
Fund Houses
₹921.71 Cr
Total Exposure
Quant Mutual Fund₹336.51 Cr (36.5%)
Kotak Mahindra Mutual Fund₹231.64 Cr (25.1%)
UTI Mutual Fund₹180.82 Cr (19.6%)
Invesco Mutual Fund₹140.39 Cr (15.2%)
PGIM India Mutual Fund₹14.67 Cr (1.6%)
Others₹17.70 Cr (1.9%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 02 Aug 2023 | Other | Annual General Meeting |
| 22 Dec 2022 | Other | Extra Ordinary General Meeting |
| 06 Jul 2022 | Other | Annual General Meeting |
| 04 Aug 2021 | Other | Annual General Meeting |
| 18 Jun 2021 | Other | Extra Ordinary General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.